In an effort to provide more targeted therapies for cancer patients, the Technical University of Munich (TUM), the TUM University Hospital, and ITM Isotope Technologies Munich SE have signed a research framework agreement. Through this partnership, the institutions aim to enhance their collaboration and involvement of the FRM II research reactor in the fields of nuclear medicine, radiopharmacy, and medical isotope technology.